Compare RNXT & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | MKTW |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4M | 34.1M |
| IPO Year | 2021 | 2020 |
| Metric | RNXT | MKTW |
|---|---|---|
| Price | $0.83 | $13.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $8.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 158.7K | 9.5K |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 5.86% |
| EPS Growth | 59.60 | ★ 260.00 |
| EPS | N/A | ★ 1.54 |
| Revenue | $43,000.00 | ★ $512,403,000.00 |
| Revenue This Year | $2,995.35 | N/A |
| Revenue Next Year | $219.61 | N/A |
| P/E Ratio | ★ N/A | $8.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $0.48 |
| 52 Week High | $1.45 | $21.74 |
| Indicator | RNXT | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 37.65 |
| Support Level | $0.82 | $13.50 |
| Resistance Level | $1.07 | $17.39 |
| Average True Range (ATR) | 0.06 | 0.61 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 9.48 | 12.39 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.